Literature DB >> 18687801

L-methionine-dl-sulfoxide metabolism and toxicity in freshly isolated mouse hepatocytes: gender differences and inhibition with aminooxyacetic acid.

Joseph T Dever1, Adnan A Elfarra.   

Abstract

L-methionine-dl-sulfoxide (n class="Chemical">MetO) is an L-methionine (Met) metabolite, but its role in Met metabolism and toxicity is not clear. In this study, MetO uptake, metabolism to Met, cytotoxicity, and glutathione (GSH) and glutathione disulfide (GSSG) status were characterized in freshly isolated mouse hepatocytes incubated at 37 degrees C with 0 to 30 mM MetO for 0 to 5 h. In male hepatocytes, dose-dependent cytotoxicity concomitant with GSH depletion without GSSG formation occurred after exposure to 20 or 30 mM MetO but not after exposure to 10 mM MetO. Interestingly, female hepatocytes exposed to 30 mM MetO showed no cytotoxicity and exhibited increased intracellular GSH levels compared with control hepatocytes. Male hepatocytes had approximately 2-fold higher levels of intracellular Met-d-O or Met-l-O after MetO (30 mM) exposure for 0 to 1.5 h compared with female hepatocytes. In hepatocytes of both genders, Met-l-O was detected at nearly 5-fold higher levels than Met-d-O, and no significant increase in cellular Met levels was detected. Addition of aminooxyacetic acid (AOAA), an inhibitor of transamination reactions, to MetO-exposed male hepatocytes resulted in higher cellular Met-d-O and Met-l-O levels and decreased the cytotoxicity of MetO. Interestingly, exposure of control male hepatocytes to AOAA selectively increased cellular Met-d-O levels to levels similar to those observed after exposure to MetO (30 mM). Analysis of MetO transamination activity by glutamine transaminase K in mouse liver cytosol revealed similar rates of MetO transamination in cytosol of both genders. Taken together, these results provide evidence for stereoselective oxidation of Met to Met-d-O under physiological conditions and suggest a major role for MetO transamination in MetO metabolism and toxicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18687801      PMCID: PMC2574602          DOI: 10.1124/dmd.108.023390

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  36 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Transsulfuration in an adult with hepatic methionine adenosyltransferase deficiency.

Authors:  W A Gahl; I Bernardini; J D Finkelstein; A Tangerman; J J Martin; H J Blom; K D Mullen; S H Mudd
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

3.  Oxidative decarboxylation of 4-methylthio-2-oxobutyrate by branched-chain 2-oxo acid dehydrogenase complex.

Authors:  S M Jones; S J Yeaman
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

4.  Methanethiol and dimethylsulfide formation from 3-methylthiopropionate in human and rat hepatocytes.

Authors:  H J Blom; J P van den Elzen; S H Yap; A Tangerman
Journal:  Biochim Biophys Acta       Date:  1988-11-18

5.  The effect of methanethiol and methionine toxicity on the activities of cytochrome c oxidase and enzymes involved in protection from peroxidative damage.

Authors:  A Finkelstein; N J Benevenga
Journal:  J Nutr       Date:  1986-02       Impact factor: 4.798

6.  Methionine infusion reproduces liver injury of parenteral nutrition cholestasis.

Authors:  R L Moss; A L Haynes; A Pastuszyn; R H Glew
Journal:  Pediatr Res       Date:  1999-05       Impact factor: 3.756

7.  Aminotransferase, L-amino acid oxidase and beta-lyase reactions involving L-cysteine S-conjugates found in allium extracts. Relevance to biological activity?

Authors:  Arthur J L Cooper; John T Pinto
Journal:  Biochem Pharmacol       Date:  2005-01-15       Impact factor: 5.858

8.  Species and sex differences in expression of flavin-containing monooxygenase form 3 in liver and kidney microsomes.

Authors:  S L Ripp; K Itagaki; R M Philpot; A A Elfarra
Journal:  Drug Metab Dispos       Date:  1999-01       Impact factor: 3.922

9.  Effects of equimolar doses of L-methionine, D-methionine and L-methionine-dl-sulfoxide on plasma and urinary amino acid levels in normal adult humans.

Authors:  L D Stegink; E F Bell; L J Filer; E E Ziegler; D W Andersen; F H Seligson
Journal:  J Nutr       Date:  1986-07       Impact factor: 4.798

10.  Flavin-containing monooxygenase (FMO)-dependent metabolism of methionine and evidence for FMO3 being the major FMO involved in methionine sulfoxidation in rabbit liver and kidney microsomes.

Authors:  R J Duescher; M P Lawton; R M Philpot; A A Elfarra
Journal:  J Biol Chem       Date:  1994-07-01       Impact factor: 5.157

View more
  6 in total

Review 1.  The biochemical and toxicological significance of hypermethionemia: new insights and clinical relevance.

Authors:  Joseph T Dever; Adnan A Elfarra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-09-28       Impact factor: 4.481

2.  Gender differences in methionine accumulation and metabolism in freshly isolated mouse hepatocytes: potential roles in toxicity.

Authors:  Joseph T Dever; Adnan A Elfarra
Journal:  Toxicol Appl Pharmacol       Date:  2009-02-21       Impact factor: 4.219

Review 3.  International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors.

Authors:  Csaba Szabo; Andreas Papapetropoulos
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

4.  Acute administration of methionine and/or methionine sulfoxide impairs redox status and induces apoptosis in rat cerebral cortex.

Authors:  Mayara Sandrielly Pereira Soares; Cassiana Macagnan Viau; Jenifer Saffi; Marcelo Zanusso Costa; Tatiane Morgana da Silva; Pathise Souto Oliveira; Juliana Hofstatter Azambuja; Alethéa Gatto Barschak; Elizandra Braganhol; Angela T S Wyse; Roselia Maria Spanevello; Francieli Moro Stefanello
Journal:  Metab Brain Dis       Date:  2017-07-04       Impact factor: 3.584

5.  HDAC8 and STAT3 repress BMF gene activity in colon cancer cells.

Authors:  Y Kang; H Nian; P Rajendran; E Kim; W M Dashwood; J T Pinto; L A Boardman; S N Thibodeau; P J Limburg; C V Löhr; W H Bisson; D E Williams; E Ho; R H Dashwood
Journal:  Cell Death Dis       Date:  2014-10-16       Impact factor: 8.469

6.  Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer.

Authors:  Nadiya Druzhyna; Bartosz Szczesny; Gabor Olah; Katalin Módis; Antonia Asimakopoulou; Athanasia Pavlidou; Petra Szoleczky; Domokos Gerö; Kazunori Yanagi; Gabor Törö; Isabel López-García; Vassilios Myrianthopoulos; Emmanuel Mikros; John R Zatarain; Celia Chao; Andreas Papapetropoulos; Mark R Hellmich; Csaba Szabo
Journal:  Pharmacol Res       Date:  2016-08-10       Impact factor: 7.658

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.